Provention Bio, Inc. (PRVB) Stock Analysis
DELISTED 2023
What happened to Provention Bio, Inc. (PRVB) stock?
Provention Bio, Inc. (PRVB) no longer trades on public markets. It was delisted in April 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2023
- Last recorded price (historical):
- $24.98 (last quote on record before the April 2023 delisting; historical, not a current quote)
Market cap $2.38B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Provention Bio, Inc. (PRVB). Provention Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Red Bank, US, focused on developing therapeutics to intercept and prevent immune-mediated diseases.
Last analyzed: Jun 14, 2026Provention Bio, Inc. (PRVB) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PRVB shares?
No. PRVB stopped trading on public markets in April 2023, so the shares are not available through a broker. Anything you see quoted for PRVB elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PRVB stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Provention Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.